Search

Impact on the corneal and anterior chamber characteristics after femtosecond laser cataract surgery

Femtosecond laser cataract surgery (FLACS) is being increasingly used in the preparation for cataract surgery. Benefits of circular capsulorrhexis and reduced phacoemulsification energy have been shown in the literature. This study was designed to assess the anterior chamber characteristics and...

Intermittent exotropia with a positive Bielchowsky head-tilt test

This is a retrospective study from Korea, of 118 patients’ charts with intermittent exotropia (IXT) and divided into two groups; 50 patients showed positive Bielchowsky head tilt test (BHTT) and 68 with negative BHTT. Significant differences (p<0.05) in the parameters...

ROP ocular outcomes after Bevacizumab treatment

The relationship between refractive outcomes and biometric parameters were evaluated following intravitreal Bevacizumab (IVB) monotherapy. Sixty-three infants were grouped into 1) infants treated with VB monotherapy for ROP (six with zone 1 and eight with posterior zone II retinopathy of...

PALs use for convergence excess esotropia

This retrospective study includes a disparate group of 39 esotropic patients with an accommodative element from two different clinics with differing prescribing practices. Seven children were excluded due to previous treatment or insufficient follow-up. In all patients single vision glasses...

Conjunctivochalasis and aqueous tear deficiency – which one causes symptoms?

This review sought to determine whether conjunctivochalasis (CCh) obliterates the fornix tear reservoir and thus mimics aqueous tear deficiency (ATD). Patients were divided into two groups, with aqueous tear deficiency (CCh +ATD) or without (CCh –ATD), based on results of...

Aflibercept, bevacizumab or ranibizumab for DMO

This is a two-year randomised clinical trial of 660 patients with visual acuity impairment from diabetic macular oedema (DMO) who were randomised to monthly injections of 2.0mg aflibercept, 1.25 mg bevacizumab or 0.3mg ranibizumab. Focal or grid laser was performed...

RCT of IOL type

The optical performance of pseudophakic eyes were compared after implantation of spherical and aspheric IOLs in paediatric patients after cataract surgery. This randomised controlled trial included 40 eyes of 23 patients: 20 eyes in each group. Follow-up was over three...

Optic nerve head perfusion response to reduced blood pressure and increased intraocular pressure

The purpose of this prospective study was to test the hypothesis that blood flow autoregulation in the optic nerve head has less reserve to maintain normal blood flow where there is a blood pressure induced decrease in ocular perfusion pressure...

Cyanoacrylate vs. fibrin glue

This study compared the safety and efficacy of fibrin and cyanoacrylate glue for refixating the recessed muscle to the sclera in patients undergoing strabismus surgery. The fibrin group (a) included 21 eyes of 15 patients; mean age of 11.6 ±7.49...

Ranibizumab for the treatment of age-related macular degeneration

This multicentre randomised prospective open label study compared 0.5 versus 2mg of ranibizumab in patients with submacular retinal pigment epithelial (RPE) detachment due to age-related macular degeneration. Four treatment regimens were used for the two strengths either monthly for 12...

Resection versus advancement for consecutive XT

The authors performed a retrospective review of results for patients treated with resection for consecutive exotropia in comparison to patients treated with advancement to the original insertion. The age of the resection and advancement groups averaged 33.6 and 38.2 years...